Immortalized hSAECs for RSV and UPR Studies
Corresponding Organization : University of Wisconsin–Madison
Variable analysis
- Presence or absence of RSV infection (MOI of 1.0 for 24 h)
- Treatment with tunicamycin (0.5-5 μg/ml) for indicated times
- Treatment with thapsigargin (50 nM) for indicated times
- Treatment with KIRA8 (10 μM) for indicated times
- Not explicitly mentioned
- HSAECs grown in SAGM small airway epithelial cell growth medium in 5% CO2
- Use of sucrose cushion purified RSV Long strain
- Not specified
- Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!